BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 27488530)

  • 1. JARID1B Enables Transit between Distinct States of the Stem-like Cell Population in Oral Cancers.
    Facompre ND; Harmeyer KM; Sole X; Kabraji S; Belden Z; Sahu V; Whelan K; Tanaka K; Weinstein GS; Montone KT; Roesch A; Gimotty PA; Herlyn M; Rustgi AK; Nakagawa H; Ramaswamy S; Basu D
    Cancer Res; 2016 Sep; 76(18):5538-49. PubMed ID: 27488530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
    Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
    Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of JARID1B promotes differentiation via SHIP1/AKT signaling in human hypopharyngeal squamous cell carcinoma.
    Zhang J; An X; Han Y; Ma R; Yang K; Zhang L; Chi J; Li W; Llobet-Navas D; Xu Y; Jiang Y
    Cell Death Dis; 2016 Sep; 7(9):e2358. PubMed ID: 27584795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The low-affinity nerve growth factor receptor p75NTR identifies a transient stem cell-like state in oral squamous cell carcinoma cells.
    Osman TA; Parajuli H; Sapkota D; Ahmed IA; Johannessen ACh; Costea DE
    J Oral Pathol Med; 2015 Jul; 44(6):410-9. PubMed ID: 25212757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of JARID1B induces cellular senescence in human colorectal cancer.
    Ohta K; Haraguchi N; Kano Y; Kagawa Y; Konno M; Nishikawa S; Hamabe A; Hasegawa S; Ogawa H; Fukusumi T; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Noguchi Y; Ozaki M; Kudo T; Sakai D; Satoh T; Fukami M; Ishii M; Yamamoto H; Doki Y; Mori M; Ishii H
    Int J Oncol; 2013 Apr; 42(4):1212-8. PubMed ID: 23354547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of ovatodiolide, a macrocyclic diterpenoid, as a potential inhibitor of oral cancer stem-like cells properties via the inhibition of the JAK2/STAT3/JARID1B signal circuit.
    Lin CS; Bamodu OA; Kuo KT; Huang CM; Liu SC; Wang CH; Tzeng YM; Chao TY; Yeh CT
    Phytomedicine; 2018 Jul; 46():93-103. PubMed ID: 30097127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLU-1/JARID1B overexpression predicts proliferation properties in head and neck squamous cell carcinoma.
    Cui Z; Song L; Hou Z; Han Y; Hu Y; Wu Y; Chen W; Mao L
    Oncol Rep; 2015 May; 33(5):2454-60. PubMed ID: 25777981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for the JARID1B stem cell marker for continuous melanoma growth.
    Held M; Bosenberg M
    Pigment Cell Melanoma Res; 2010 Aug; 23(4):481-3. PubMed ID: 20546534
    [No Abstract]   [Full Text] [Related]  

  • 9. EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect.
    Xu Q; Zhang Q; Ishida Y; Hajjar S; Tang X; Shi H; Dang CV; Le AD
    Oncotarget; 2017 Feb; 8(6):9557-9571. PubMed ID: 27926487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Jarid1b promotes epidermal differentiation by mediating the repression of Ship1 and activation of the AKT/Ovol1 pathway.
    Sun X; Li Z; Niu Y; Zhao L; Huang Y; Li Q; Zhang S; Chen T; Fu T; Yang T; An X; Jiang Y; Zhang J
    Cell Prolif; 2019 Sep; 52(5):e12638. PubMed ID: 31152465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Cell CD44 Mediates Macrophage/Monocyte-Driven Regulation of Head and Neck Cancer Stem Cells.
    Gomez KE; Wu F; Keysar SB; Morton JJ; Miller B; Chimed TS; Le PN; Nieto C; Chowdhury FN; Tyagi A; Lyons TR; Young CD; Zhou H; Somerset HL; Wang XJ; Jimeno A
    Cancer Res; 2020 Oct; 80(19):4185-4198. PubMed ID: 32816856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44+ cancer cell-induced metastasis: A feasible neck metastasis model.
    Wu TF; Chen L; Bu LL; Gao J; Zhang WF; Jia J
    Eur J Pharm Sci; 2017 Apr; 101():243-250. PubMed ID: 28215944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD24+ tumor-initiating cells from oral squamous cell carcinoma induce initial angiogenesis in vivo.
    Zimmerer RM; Ludwig N; Kampmann A; Bittermann G; Spalthoff S; Jungheim M; Gellrich NC; Tavassol F
    Microvasc Res; 2017 Jul; 112():101-108. PubMed ID: 28344048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lin28B/Let-7 Regulates Expression of Oct4 and Sox2 and Reprograms Oral Squamous Cell Carcinoma Cells to a Stem-like State.
    Chien CS; Wang ML; Chu PY; Chang YL; Liu WH; Yu CC; Lan YT; Huang PI; Lee YY; Chen YW; Lo WL; Chiou SH
    Cancer Res; 2015 Jun; 75(12):2553-65. PubMed ID: 25858147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expression of JMJD6 is associated with oral carcinogenesis and maintains cancer stemness properties.
    Lee CR; Lee SH; Rigas NK; Kim RH; Kang MK; Park NH; Shin KH
    Carcinogenesis; 2016 Feb; 37(2):119-128. PubMed ID: 26645717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of JARID1B expression inhibits cell proliferation, induces apoptosis and blocks cell cycle in human acute lymphoblastic leukemia cells.
    Huang YQ; Zou Y; Zheng RJ; Ma XD
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1366-1373. PubMed ID: 29565495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JARID1B promotes colorectal cancer proliferation and Wnt/β-catenin signaling via decreasing CDX2 level.
    Huang D; Xiao F; Hao H; Hua F; Luo Z; Huang Z; Li Q; Chen S; Cheng X; Zhang X; Fang W; Hu X; Liu F
    Cell Commun Signal; 2020 Oct; 18(1):169. PubMed ID: 33109187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leading edge or tumor core: Intratumor cancer stem cell niches in oral cavity squamous cell carcinoma and their association with stem cell function.
    Chowdhury FN; Reisinger J; Gomez KE; Chimed TS; Thomas CM; Le PN; Miller B; Morton JJ; Nieto CM; Somerset HL; Wang XJ; Keysar SB; Jimeno A
    Oral Oncol; 2019 Nov; 98():118-124. PubMed ID: 31586893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer.
    Yu CC; Tsai LL; Wang ML; Yu CH; Lo WL; Chang YC; Chiou GY; Chou MY; Chiou SH
    Cancer Res; 2013 Jun; 73(11):3425-40. PubMed ID: 23548270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CK2 phosphorylates and inhibits TAp73 tumor suppressor function to promote expression of cancer stem cell genes and phenotype in head and neck cancer.
    Lu H; Yan C; Quan XX; Yang X; Zhang J; Bian Y; Chen Z; Van Waes C
    Neoplasia; 2014 Oct; 16(10):789-800. PubMed ID: 25379016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.